DR6.F - ACADIA Pharmaceuticals Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Currency in EUR

Valuation Measures

Market Cap (intraday) 5
7.01B
Enterprise Value 3
6.43B
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
23.35
Price/Book (mrq)
10.27
Enterprise Value/Revenue 3
21.42
Enterprise Value/EBITDA 6
-25.28

Trading Information

Stock Price History

Beta (3Y Monthly) 2.82
52-Week Change 3186.97%
S&P500 52-Week Change 318.19%
52 Week High 347.46
52 Week Low 312.76
50-Day Moving Average 340.23
200-Day Moving Average 330.18

Share Statistics

Avg Vol (3 month) 335
Avg Vol (10 day) 385
Shares Outstanding 5154.02M
Float 112.89M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -82.48%
Operating Margin (ttm)-85.71%

Management Effectiveness

Return on Assets (ttm)-31.18%
Return on Equity (ttm)-54.28%

Income Statement

Revenue (ttm)300.32M
Revenue Per Share (ttm)2.12
Quarterly Revenue Growth (yoy)62.20%
Gross Profit (ttm)18.31M
EBITDA -254.51M
Net Income Avi to Common (ttm)-247.72M
Diluted EPS (ttm)-1.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)683.85M
Total Cash Per Share (mrq)4.44
Total Debt (mrq)10.27M
Total Debt/Equity (mrq)1.49
Current Ratio (mrq)10.96
Book Value Per Share (mrq)4.49

Cash Flow Statement

Operating Cash Flow (ttm)-160.5M
Levered Free Cash Flow (ttm)-73.02M